TXG
10x Genomics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$18.79
-0.15 ▼ -0.79%
🌙 3월 13일 6:51 PM ET (한국 3/14 07:51)
$18.64
-0.15 ▼ -0.80%
| Index | RUT | P/E | - | EPS (ttm) | -0.35 | Insider Own | 11.61% | Shs Outstand | 0.12B | Perf Week | -9.71% |
| Market Cap | 2.40B | Forward P/E | - | EPS next Y | 23.14% | Insider Trans | -0.56% | Shs Float | 0.11B | Perf Month | -1.88% |
| Enterprise Value | 1.96B | PEG | - | EPS next Q | -0.27 | Inst Own | 95.83% | Short Float | 14.52% | Perf Quarter | 7.19% |
| Income | -0.04B | P/S | 3.73 | EPS this Y | -139.79% | Inst Trans | 0.1% | Short Ratio | 6.58 | Perf Half Y | 43.87% |
| Sales | 0.64B | P/B | 3.01 | EPS next 5Y | -14.57% | ROA | -4.44% | Short Interest | 16.40M | Perf YTD | 15.21% |
| Book/sh | 6.24 | P/C | 4.59 | EPS past 3/5Y | 37.9% 42.1% | ROE | -5.78% | 52W High | -20.25% ($23.56) | Perf Year | 90.18% |
| Cash/sh | 4.1 | P/FCF | 18.45 | Sales past 3/5Y | 7.57% 16.55% | ROIC | -5.01% | 52W Low | 177.14% ($6.78) | Perf 3Y | -60.47% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 77.07% | Gross Margin | 70.38% | Volatility(W/M) | 5.58% 7.1% | Perf 5Y | -88.26% |
| Dividend TTM | - | EV/Sales | 3.05 | Sales Y/Y TTM | 5.25% | Oper. Margin | -16.51% | ATR (14) | 1.27 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.09 | EPS Q/Q | 68.28% | Profit Margin | -6.77% | RSI (14) | 40.43 | Recom | 2.53 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.46 | Sales Q/Q | 0.61% | SMA20 | -7.75% ($20.37) | Beta | 2.24 | Target Price | $20.07 |
| Payout | - | Debt/Eq | 0.11 | Earnings | 2000000 | SMA50 | -6.62% ($20.12) | Rel Volume | 0.7 | Prev Close | $18.94 |
| Employees | 1178 | LT Debt/Eq | 0.09 | EPS/Sales Surpr. | 35.9% 3.99% | SMA200 | 24.06% ($15.15) | Avg Volume(3M) | 2.49M | Price | $18.79 |
| IPO | 2019/9/12 | Option/Short | Yes/Yes | Trades | 17476 | Volume | 1,735,644 | Change | -0.79% |
뉴스 로딩 중...